Fertility Assessment
Ovarian reserve panel with AMH, FSH, LH, and Estradiol.
Follicle-stimulating hormone (FSH) drives egg maturation and is a key indicator of ovarian reserve and menopausal status. Rising levels may signal your body is working harder to stimulate ovulation. Your healthcare provider can help you understand what FSH means for your fertility and cycle.
Doctor's Assessment Included
| Sex | Cycle phase | Menopausal status | Reference range (U/L) | Relative scale |
|---|---|---|---|---|
| Female | · Follicular | 3,5–12,5 U/L |
3,5
12,5
|
|
| Female | · Ovulatory | 4,7–21,5 U/L |
4,7
21,5
|
|
| Female | · Luteal | 1,7–7,7 U/L |
1,7
7,7
|
|
| Female | · Postmenopausal | 25,8–134,8 U/L |
25,8
134,8
|
Bijsluiterwaarde: 5e-95e percentiel per subgroep (n = 319 mannen, mediaan 4,6; 376 folliculair, mediaan 6,9; 56 ovulatie, mediaan 12,3; 349 luteaal, mediaan 3,6; 181 postmenopauzaal, mediaan 67). Een hormoonreferentiewaarde is assay-specifiek; deze waarden gelden voor de Roche Elecsys-methode.
Source: Roche Diagnostics Reference population: Roche referentiecohort (Elecsys FSH bijsluiter)
Reference ranges may vary between laboratories. When you order a test, a BIG-registered doctor assesses your personal results in context. For treatment decisions, discuss your results with your GP.
Check your own valueThis test measures the concentration of follicle-stimulating hormone in your blood. FSH is released by the pituitary gland and stimulates the ovaries to produce eggs or the testes to produce sperm. Your healthcare provider may interpret FSH alongside LH and sex hormones for context.
FSH is central to understanding your reproductive timeline. Elevated levels could suggest diminishing ovarian reserve or approaching menopause, while low levels may indicate disrupted ovulation. Tracking FSH with your healthcare provider may provide valuable insight into your fertility and cycle health.
Your healthcare provider may recommend FSH testing when evaluating fertility, investigating irregular or absent menstrual periods, assessing menopausal status, or examining delayed puberty. For women, testing is typically performed early in the menstrual cycle. Consult your provider for timing advice.
Low FSH may indicate pituitary dysfunction, hypothalamic amenorrhea, or PCOS. Consult with a gynecologist or reproductive endocrinologist.
High FSH may indicate diminished ovarian reserve, menopause, or premature ovarian failure. Consider fertility consultation if planning pregnancy.
Maintaining a healthy weight, managing stress, and ensuring adequate nutrition may support healthy pituitary function and FSH regulation. Avoiding excessive exercise that could disrupt hormonal balance is also important. Always discuss concerns about your reproductive health with your healthcare provider.
This marker is included in the following test panels.
Ovarian reserve panel with AMH, FSH, LH, and Estradiol.
FSH, LH, Estradiol, Progesterone, and Prolactin: key female reproductive hormones.
Assess menopausal status with FSH, Estradiol, and thyroid markers.
FSH, LH, and Estradiol: provide insight into menopausal status.
Complete female IVF intake panel: ovarian reserve, thyroid, infectious screening, immunity serology, blood group and CBC.
Everything in the IVF panel plus full thyroid, preconception nutrients, progesterone and CMV immunity.
Measure your FSH for insight into ovarian reserve and (peri)menopause. No referral needed, results within a few working days.
FSH (Follicle Stimulating Hormone)
€25,-